205 related articles for article (PubMed ID: 25822739)
1. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P
J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study of the pyridine moiety of isothiazolo[4,3-b]pyridines as antiviral agents targeting cyclin G-associated kinase.
Martinez-Gualda B; Pu SY; Froeyen M; Herdewijn P; Einav S; De Jonghe S
Bioorg Med Chem; 2020 Jan; 28(1):115188. PubMed ID: 31757682
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Pu SY; Wouters R; Schor S; Rozenski J; Barouch-Bentov R; Prugar LI; O'Brien CM; Brannan JM; Dye JM; Herdewijn P; De Jonghe S; Einav S
J Med Chem; 2018 Jul; 61(14):6178-6192. PubMed ID: 29953812
[TBL] [Abstract][Full Text] [Related]
4. A Scaffold-Hopping Strategy toward the Identification of Inhibitors of Cyclin G Associated Kinase.
Wouters R; Tian J; Herdewijn P; De Jonghe S
ChemMedChem; 2019 Jan; 14(2):237-254. PubMed ID: 30548533
[TBL] [Abstract][Full Text] [Related]
5. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines.
Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S
Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544
[TBL] [Abstract][Full Text] [Related]
6. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.
Neveu G; Ziv-Av A; Barouch-Bentov R; Berkerman E; Mulholland J; Einav S
J Virol; 2015 Apr; 89(8):4387-404. PubMed ID: 25653444
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S
Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888
[TBL] [Abstract][Full Text] [Related]
8. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.
Bekerman E; Neveu G; Shulla A; Brannan J; Pu SY; Wang S; Xiao F; Barouch-Bentov R; Bakken RR; Mateo R; Govero J; Nagamine CM; Diamond MS; De Jonghe S; Herdewijn P; Dye JM; Randall G; Einav S
J Clin Invest; 2017 Apr; 127(4):1338-1352. PubMed ID: 28240606
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors.
Asquith CRM; Tizzard GJ; Bennett JM; Wells CI; Elkins JM; Willson TM; Poso A; Laitinen T
ChemMedChem; 2020 Jul; 15(13):1200-1215. PubMed ID: 32358915
[TBL] [Abstract][Full Text] [Related]
10. Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.
Asquith CRM; Laitinen T; Bennett JM; Godoi PH; East MP; Tizzard GJ; Graves LM; Johnson GL; Dornsife RE; Wells CI; Elkins JM; Willson TM; Zuercher WJ
ChemMedChem; 2018 Jan; 13(1):48-66. PubMed ID: 29072804
[TBL] [Abstract][Full Text] [Related]
11. Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.
Asquith CRM; Naegeli KM; East MP; Laitinen T; Havener TM; Wells CI; Johnson GL; Drewry DH; Zuercher WJ; Morris DC
J Med Chem; 2019 May; 62(9):4772-4778. PubMed ID: 30973735
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Structure-Activity Relationships of 3,5-Disubstituted-pyrrolo[2,3- b]pyridines as Inhibitors of Adaptor-Associated Kinase 1 with Antiviral Activity.
Verdonck S; Pu SY; Sorrell FJ; Elkins JM; Froeyen M; Gao LJ; Prugar LI; Dorosky DE; Brannan JM; Barouch-Bentov R; Knapp S; Dye JM; Herdewijn P; Einav S; De Jonghe S
J Med Chem; 2019 Jun; 62(12):5810-5831. PubMed ID: 31136173
[TBL] [Abstract][Full Text] [Related]
13. SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).
Asquith CRM; Berger BT; Wan J; Bennett JM; Capuzzi SJ; Crona DJ; Drewry DH; East MP; Elkins JM; Fedorov O; Godoi PH; Hunter DM; Knapp S; Müller S; Torrice CD; Wells CI; Earp HS; Willson TM; Zuercher WJ
J Med Chem; 2019 Mar; 62(5):2830-2836. PubMed ID: 30768268
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib and luteolin cause growth arrest of human prostate cancer PC-3 cells via inhibition of cyclin G-associated kinase and induction of miR-630.
Sakurai MA; Ozaki Y; Okuzaki D; Naito Y; Sasakura T; Okamoto A; Tabara H; Inoue T; Hagiyama M; Ito A; Yabuta N; Nojima H
PLoS One; 2014; 9(6):e100124. PubMed ID: 24971999
[TBL] [Abstract][Full Text] [Related]
15. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
[TBL] [Abstract][Full Text] [Related]
16. 4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR).
Tsou HR; MacEwan G; Birnberg G; Zhang N; Brooijmans N; Toral-Barza L; Hollander I; Ayral-Kaloustian S; Yu K
Bioorg Med Chem Lett; 2010 Apr; 20(7):2259-63. PubMed ID: 20188551
[TBL] [Abstract][Full Text] [Related]
17. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
[TBL] [Abstract][Full Text] [Related]
18. Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.
Takebe Y; Saucedo CJ; Lund G; Uenishi R; Hase S; Tsuchiura T; Kneteman N; Ramessar K; Tyrrell DL; Shirakura M; Wakita T; McMahon JB; O'Keefe BR
PLoS One; 2013; 8(5):e64449. PubMed ID: 23700478
[TBL] [Abstract][Full Text] [Related]
19. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
[TBL] [Abstract][Full Text] [Related]
20. Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
Asquith CRM; Laitinen T; Bennett JM; Wells CI; Elkins JM; Zuercher WJ; Tizzard GJ; Poso A
ChemMedChem; 2020 Jan; 15(1):26-49. PubMed ID: 31675459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
